Anaptysbio (ANAB) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to -$19.6 million.
- Anaptysbio's Non Operating Income fell 9408.56% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.9 million, marking a year-over-year decrease of 20636.55%. This contributed to the annual value of -$30.3 million for FY2024, which is 394251.27% down from last year.
- Latest data reveals that Anaptysbio reported Non Operating Income of -$19.6 million as of Q3 2025, which was down 9408.56% from -$12.4 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Non Operating Income ranged from a high of $424000.0 in Q3 2023 and a low of -$19.6 million during Q3 2025
- Over the past 5 years, Anaptysbio's median Non Operating Income value was -$1.7 million (recorded in 2024), while the average stood at -$4.6 million.
- In the last 5 years, Anaptysbio's Non Operating Income skyrocketed by 11095.89% in 2023 and then tumbled by 1505000.0% in 2024.
- Quarter analysis of 5 years shows Anaptysbio's Non Operating Income stood at -$1.4 million in 2021, then skyrocketed by 69.88% to -$416000.0 in 2022, then surged by 80.77% to -$80000.0 in 2023, then crashed by 15050.0% to -$12.1 million in 2024, then tumbled by 61.64% to -$19.6 million in 2025.
- Its Non Operating Income stands at -$19.6 million for Q3 2025, versus -$12.4 million for Q2 2025 and -$11.7 million for Q1 2025.